|
Volumn 6, Issue 10, 2010, Pages 780-783
|
Lessons learned from the H1N1 2009 pandemic
|
Author keywords
Adjuvant; H1N1; Influenza; Pandemic; Vaccine
|
Indexed keywords
ADVAX;
DEPOVACCINE FP 01;
FLUVAX;
GAMMAFLU;
IMMUNOLOGICAL ADJUVANT;
INFLUENZA VACCINE;
LIVE VACCINE;
RECOMBINANT VACCINE;
UNCLASSIFIED DRUG;
ASIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
HUMAN;
INFLUENZA VACCINATION;
INFLUENZA VIRUS A H1N1;
INTERNATIONAL COOPERATION;
PANDEMIC INFLUENZA;
SINGAPORE;
VACCINE PRODUCTION;
ADJUVANTS, IMMUNOLOGIC;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
PANDEMICS;
SINGAPORE;
VACCINATION;
VACCINES, ATTENUATED;
VACCINES, INACTIVATED;
VACCINES, SYNTHETIC;
|
EID: 78649388556
PISSN: 15548600
EISSN: 15548619
Source Type: Journal
DOI: 10.4161/hv.6.10.12981 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|